Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

An assessment of the current Chlamydia trachomatis laboratory practices in Germany.

Schmidt D, Päschke H, Bremer V, Hamouda O, Reischl U, Sailer A, Haar K.

Gesundheitswesen. 2014 Oct;76(10):e44-50. doi: 10.1055/s-0033-1355406. Epub 2013 Nov 7.

PMID:
24203685
2.

Evaluation of laboratory testing methods for Chlamydia trachomatis infection in the era of nucleic acid amplification.

Battle TJ, Golden MR, Suchland KL, Counts JM, Hughes JP, Stamm WE, Holmes KK.

J Clin Microbiol. 2001 Aug;39(8):2924-7.

3.
4.

Value of repeat testing using Cepheid GeneXpert CT/NG for indeterminate PCR results when diagnosing Chlamydia trachomatis and Neisseria gonorrhoeae.

Parcell BJ, Ratnayake L, Kaminski G, Olver WJ, Yirrell DL.

Int J STD AIDS. 2015 Jan;26(1):65-7. doi: 10.1177/0956462414531938. Epub 2014 May 8.

PMID:
24810211
5.
7.

Prevalence of pharyngeal and rectal Chlamydia trachomatis and Neisseria gonorrhoeae infections among men who have sex with men in Germany.

Dudareva-Vizule S, Haar K, Sailer A, Wisplinghoff H, Wisplinghoff F, Marcus U; PARIS study group..

Sex Transm Infect. 2014 Feb;90(1):46-51. doi: 10.1136/sextrans-2012-050929. Epub 2013 Aug 6.

PMID:
23920398
8.

Risk factors for Chlamydia trachomatis infection in adolescents: results from a representative population-based survey in Germany, 2003-2006.

Haar K, Bremer V, Houareau C, Meyer T, Desai S, Thamm M, Hamouda O.

Euro Surveill. 2013 Aug 22;18(34). pii: 20562.

9.

Epidemiological analysis of Chlamydia trachomatis and Neisseria gonorrhoeae in Saskatoon Health Region.

Lemstra M, Neudorf C, Opondo J, de Bruin P, Grauer K, Wright J.

Can J Public Health. 2007 Mar-Apr;98(2):134-7.

PMID:
17441538
10.
11.
12.

External quality assessment program for Chlamydia trachomatis diagnostic testing by nucleic acid amplification assays.

Land S, Tabrizi S, Gust A, Johnson E, Garland S, Dax EM.

J Clin Microbiol. 2002 Aug;40(8):2893-6.

13.

The role of Medicaid managed care interventions in Chlamydia screening by physicians.

Pourat N, Kominski GF, Nihalani J, Neiman R, Bolan G.

Sex Transm Dis. 2011 Apr;38(4):286-92. doi: 10.1097/OLQ.0b013e3181ffa90c.

PMID:
21233791
14.
15.

Diagnostic relevance of simultaneous testing for Chlamydia trachomatis and Neisseria gonorrhoeae.

Sakem B, Michel R, Nydegger UE, Radjenovic D, Wydler M, Risch M, Risch L.

Infection. 2011 Jun;39(3):231-7. doi: 10.1007/s15010-011-0110-z. Epub 2011 Apr 27.

PMID:
21523404
16.

[Modern diagnosis of Chlamydia trachomatis infections].

Meyer T.

Hautarzt. 2007 Jan;58(1):24-30. Review. German.

PMID:
17180355
17.
18.

Epidemiological, social, diagnostic and economic evaluation of population screening for genital chlamydial infection.

Low N, McCarthy A, Macleod J, Salisbury C, Campbell R, Roberts TE, Horner P, Skidmore S, Sterne JA, Sanford E, Ibrahim F, Holloway A, Patel R, Barton PM, Robinson SM, Mills N, Graham A, Herring A, Caul EO, Davey Smith G, Hobbs FD, Ross JD, Egger M; Chlamydia Screening Studies Project Group..

Health Technol Assess. 2007 Mar;11(8):iii-iv, ix-xii, 1-165. Review.

20.

Gonococcal NAATs: what is the current state of play in England and Wales?

Benzie A, Alexander S, Gill N, Greene L, Thomas S, Ison C.

Int J STD AIDS. 2010 Apr;21(4):246-8. doi: 10.1258/ijsa.2010.010004.

PMID:
20378894

Supplemental Content

Support Center